1-3 of 3
Jason H. Rogers, MS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting Activated Signaling Pathways for the Treatment of IKZF1 -Deleted B Lymphoblastic Leukemia

Rohit Gupta, BA, Jason H. Rogers, MS, Xin Long, PhD, Geraldo Medrano, BS, Jaime M. Reyes, BS, Michele Redell, MD PhD, Zachary T Ball, PhD, Margaret Goodell, PhD, Rachel E. Rau, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3789.
https://doi.org/10.1182/blood-2019-127209
Published: 2019
Journal Articles

High Prevalence of PPM1D Mutations in Therapy-Related AML/MDS Is Due to Context-Specific Clonal Hematopoiesis

Joanne Hsu, BS, Tajhal Dayaram, Ayala Tovy, PhD, Etienne De Braekeleer, PhD MSc, Mira Jeong, PhD, Jason H. Rogers, MS, Feng Wang, PhD, Jianhua Zhang, PhD, Guillermo Garcia-Manero, MD, Hagop M. Kantarjian, MD, George S. Vassiliou, Andrew Futreal, PhD, Lawrence Donehower, Koichi Takahashi, MD, Margaret Goodell, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 746.
https://doi.org/10.1182/blood-2018-99-115007
Published: 2018
Journal Articles

Precise Modeling of IKZF1 Alterations in Human B-Cell Acute Lymphoblastic Leukemia Cell Lines Reveals Distinct Chemosensitivity, Homing, and Engraftment Properties

Jason H. Rogers, MS, Rohit Gupta, BS, Jaime M. Reyes, BS, Lorenzo Brunetti, MD PhD, Michael C. Gundry, BS, Tidie Song, Cade Johnson, Carlo D. D. Cristobal, BS, Margaret A. Goodell, PhD, Rachel E. Rau, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 549.
https://doi.org/10.1182/blood-2018-99-113056
Published: 2018